TWM
CME icon

Trueblood Wealth Management’s CME Group CME Stock Holding History

Trueblood Wealth Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$543K Buy
2,461
+74
+3% +$20.5K 0.19% 152
2026
Q1 		$705K Buy
2,387
+132
+6% +$39.2K 0.28% 114
2025
Q4 		$616K Buy
2,255
+217
+11% +$59K 0.24% 128
2025
Q3 		$551K Buy
2,038
+111
+6% +$30.2K 0.21% 136
2025
Q2 		$531K Buy
1,927
+5
+0.3% +$1.36K 0.22% 134
2025
Q1 		$510K Buy
1,922
+34
+2% +$8.39K 0.24% 130
2024
Q4 		$438K Buy
1,888
+884
+88% +$203K 0.22% 148
2024
Q3 		$222K Buy
+1,004
New +$208K 0.11% 211

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Trueblood Wealth Management's CME Position: Q2 2026 in Review

Trueblood Wealth Management increased its CME Group (CME) stake by 3.1% in Q2 2026, buying an estimated $20.5K and bringing the position to 2,461 shares worth $543K. The position accounts for 0.19% of the portfolio, ranked #152.

Trueblood Wealth Management first reported a position in CME in Q3 2024 and has held it in 8 quarters since. The position peaked at $705K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Trueblood Wealth Management held 2,461 shares of CME Group worth $543K as of Q2 2026.
  • Trueblood Wealth Management bought 74 CME Group shares in Q2 2026, an estimated $20.5K.
  • CME Group made up 0.19% of Trueblood Wealth Management's portfolio in Q2 2026, its #152 holding.
  • Trueblood Wealth Management first reported a position in CME Group in Q3 2024 and has held it in 8 quarters since.
  • Trueblood Wealth Management's CME Group position peaked at $705K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.